Loading

Review Article Open Access
Volume 5 | Issue 1 | DOI: https://doi.org/10.33696/Signaling.5.111

Role of Exosomal MicroRNAs in Modulating the Response of Cancer Cells to Paclitaxel Treatment

  • 1Department of Sleep Medicine Center, Shengjing Hospital of China Medical University, Shenyang, Liaoning, PR China
  • 2Department of Neurology, the First Affiliated Hospital of China Medical University, China Medical University, Shenyang, Liaoning, PR China
  • 3Department of The Fourth Otolaryngology Head and Neck surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, PR China
  • #Lanqing Zhao and Cheng Lv made equal contributions to the manuscript as co-first authors
+ Affiliations - Affiliations

Corresponding Author

Hui Xie, randh@163.com; Xiaoxu Ding, d89642319@163.com

Received Date: January 30, 2024

Accepted Date: February 29, 2024

Abstract

MicroRNAs (miRNAs) play important roles in gene regulation and have been implicated in various human diseases, including cancer. MiRNAs can be packaged in exosomes and transferred between cells. These exosomal miRNAs regulate intercellular communication and influence almost all aspects of cancer biology, including proliferation, apoptosis, invasion, metastasis, and angiogenesis. Over the last two decades, the association between exosomal miRNAs and paclitaxel resistance has been widely studied. However, the mechanisms underlying the effect of exosomal miRNAs on paclitaxel sensitivity require further research. In this review, we summarize the paclitaxel sensitivity-modulating mechanisms of exosomal miRNAs and discuss exosomal miRNAs as a novel therapeutic tool for paclitaxel resistance.

Keywords

MicroRNA, Paclitaxel, Exosome, Cancer, Drug-resistance

Author Information X